# Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

> **NCT00572559** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 149 (actual)

## Conditions studied

- Pneumonia, Ventilator-Associated

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Linezolid

## Key facts

- **NCT ID:** NCT00572559
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2010-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572559, "Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00572559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*